通过R-2-基氨酸介导的KDM4A的抑制会损害端粒完整性
Florence Couteau1, Laurence M Gagné1,2, Karine Boulay1
1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Qc, H1T 2M4, Canada.
Nucleic acids research
|June 11, 2025
概括
突变的异酸盐脱酶 (IDH1/2) 产生R-2HG,抑制KDM4A. 这导致端粒功能障碍和基因组不稳定,推动脑癌的发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 影响细胞代谢的基因突变在癌症中很常见.
- 产生R-2HG的IDH1/2突变是低度质瘤的早期事件.
- R-2HG 抑制了依赖α-甲酸盐 (αKG) 的酶,包括KDM4A.
研究的目的:
- 阐明将R-2HG生产与质生成联系起来的分子机制.
- 调查KDM4A抑制在IDH突变质瘤中的作用.
- 了解R-2HG如何影响细胞过程,如衰老和端粒维护.
主要方法:
- 用R-2HG治疗和细胞衰老的评估.
- 在表达突变IDH1或接受R-2HG治疗的细胞中分析端粒功能障碍.
- 调查KDM4A局部化及其对端粒H3K9的影响.
- 研究复制叉的进展和SMARCAL1.1的作用.
主要成果:
- R-2HG治疗诱导了p53依赖的细胞衰老.
- 通过KDM4A抑制,IDH1突变或R-2HG暴露导致端粒功能障碍.
- 在端粒中,KDM4A调节H3K9(me3);R-2HG减少复制分叉的进展.
- SMARCAL1 枯竭可以挽救由 R-2HG 或 KDM4A 枯竭引起的端粒缺陷.
结论:
- IDH1/2突变促进了R-2HG的产生,抑制了KDM4A.
- 这种抑制会导致端粒DNA复制缺陷和功能障碍.
- 这些发现建立了一个模型,KDM4A抑制通过基因组不稳定性导致质生成.
相关概念视频
Telomeres and Telomerase
23.2K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K


